Cardlytics (CDLX) Tops Q1 EPS by 13c

Cardlytics (NASDAQ: CDLX) reported Q1 EPS of ($0.23), $0.13 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $36 million versus the consensus estimate of $36.11 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Goldman lowers Mattel rating to Sell on macro and execution risks; shares dip
• nVent Electric (NVT) PT Raised to $220; Bernstein SocGen: 'Our top pick going into earnings'
• Piper Sandler Reiterates Overweight Rating on Reddit (RDDT)